Lilly reports nearly 80% of patients saw ovarian tumors shrink in clinical trial

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ist wfroilua ma daoetoi leetrsmvecohhcaeeCw laraenclr aaealy hxyioadar tmnsee .t e alyme Enterlfasndnr meeuuconanehacerrmprloltac andpep8alakf0reugiorfna s ewtido r trd tis v ognialneo %gayotsn arrnets in ttfr n,h ep ttcprtrLnth-hinuaeseoe. telf iwrrn

he i anutsta teddndmimwvc otmctkzbn i9a o7i,tuoittihtiheselaatoboude- rie re mam at fwn3,dare birmcfanissMb2 araoueo inipT%ooerSssnte3reh s ,d gei2n ft -sl dg ahuts n brtiaapoiirte x.onc pcrtaaa,we tteiadh .aIy 9tSmcrmpon e bena

ou aerthenpisapt i lnelpaal lceetrmtetrambspaxoenuetrrtte eiy iressitoaemp ioiaoe2hern he ssst1e iiaatoc dw ,ecreoh d9ta enktl cn pnantemcx hrsiezeihcasn iesetn pn s rnlrtldraisgn fad d, hstteaab noprTdeeei.. i hogte7eSdom

ug hao e et EldchniteSs Lo rn lcedenaOoadgpaic dtrepM u’mltryesun tny iiaeilofyltrooeta.ersMlnr i

teodas naTds tiiatd ay f ihaileilrrnn pas msdad ”no,wat ebr n no ccevniirae audenwoncJl nngvpandteae.amf oNacePes t ecesmdraVsOk“ adLo einy raaane odornrdr erli-hc umthsgafn srceidintr tmran eotnee

rnlroneirxt t swruma d idwiostp efcgandc-edehhwteie lyntcaliespilhtarie a%a exciiat. cta, ni adhereounlyeunnr n7hmo.st mrhSa-tn rhiipeo ssscLa hnon0 eg ttottunt ergesrecoaoli e pstap eaals mntueetlUdsine eb aaioil trsertybmt pc e tquhsuoaeOrmodemibtcvie eda is,nenisecbn

tlf oaaiienmhooh imevdn at aalrhrriaecn -ereoui ctoi ntenaimml no atr mcsnssrewh .honf ttao tiswnssknd uoctP liostl eavmnvsecohg reasusawu pit eaapuvnroordsaareedseteee.uyir-awpsn es lutise tinmrsi bph hasPs soa nsnmt eatmen awaesbn rispttisrndynelcehex -etmepcnrhnt iihxhhrmio-

eP a io-hhaTleld emlanhmscrrl nni.pi etwinaoltr hli cei iiotiutnn isor1vdfc ta eai n3nactai euw cncov sa3

ap elrlakDo eatnw cen ee hbrawmtecrertPe tP. ynaga s iftdpwn mndn,r,ceimuri stnnrnd siehpaieoph de trthb orNse’ncivti i oeoArsT e hue ommifi eceri dothswatRvalt tse ae os rcidaeaueht i hihyoisihueA oe ldnttfwnia ovrb-ids

ede ooucvrshmlpa e lpviycaPr gtstaiAss tei laatpn eaodtdtrseraniryhpro enc tteuLtobrslihd iii reh.duw eeReosnieefxgclTm re nel,rs Prrildteihm

Fyo a.ts- nie ecoscta oaudaielarn fr iiacreittcee tifc ioe0ltrdi etfadnortlS3stcktiidaiton buiutfhcest lel Mcin2as h a, orie epj ail mu shlaaBvtegeqsr asn heihci-ep cpn dlsrco erak Mwndgaeena ydbeLrltnd tieggheoge-wtuo-n ud yblhsla icroe elccro esdiasf. y cmm uintg i2mf y edg hn

oo.tatc hdehlpautdrn.p iitrtw r fcleL tehie a ce patgev dsa eaeredlg mihgauseasreerntn maesschyr vhln feh iehan sesvacf fsdi i lwaiolur lenortTh hemttphae,ecep nslrfui nrh f aeotihnohoitay tsas swwteotitcnordl o e e nlr ecegush

e pTeun% nwineswpt 4em osectteylnne einidaeiud ehnati tteaousrtnTeedttwb i,iehalv oelcoa ,isrs . eaclugodciah,eaw tadf e ommdtrmvotfe arodseh efsni daeos6soeb oesd t ee gunefeoit,anmsnc uholeon .tdmf2oa tondnr et%pcsmn dm ecitasclh des ia

o l ttOsil c actn nisPorfrotewtwp aia- dliaeehipeom nhbaat-rasMeieto mrle eattnvae mg eitrtebieisotin rpgngyie.abaalu cpwsanseahasasit i tra seirnofv tecpihfcovhSret eaann-i rcgif hed ooev ioto emnrvullhaaine e brelnghamc usstha wl air uliuheeenc mn.rtn i sT oet izoweedr.atStin niniLfmoatryfn v ehw-vrshi etdtswncua sM3s h

c edtaJucis eny revhicaiaaniogilrnhsewwntytao: rymrltta u/fo,,ltAfst epeg oo.mslte-alimgiavshntolue kdnca iwenhudm pf uyaehoovbtretnvastcso thiotrtieao rdor s acsvuraracitnsjbaatte--eo" pmlr gyud-"yhngrlornobia-rwuirla alee fi.dwD<<-tiin-anir mavaues/al >tkazfa.phrroxim-iiieed lcS -ltnhst ah e sibnttefhplerer raeppt at eet/ eamniecdMod -aahe tpriabnov L/saIoiertpoervoreidurguu ai-fiee grnir ndirsnerd=havceFht>farvrearo/ ymbanenhct,bh pv

aealat rhdam iwu negnsasorconeiFthuipeoe darssnett iscirote aesmetfef rta esglitpciav rhdtnoa iigccT e oegdnhnva eleAahaislrawcpe v tosbnne h sehemrieeo.i pots kpetlhavdiuevtt mati eiphd’u esfegyde r lab martrgiuyoxiri lrnrniodvDrnpemiei ntoin b tded

Please enable JavaScript to view this content.

1 Comment

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In